The growing role of nanotechnology in combating infectious disease

Karin Blecher Paz, Adnan Nasir, Adam Friedman

Research output: Contribution to journalReview article

112 Citations (Scopus)

Abstract

The treatment and prevention of infectious diseases is a major part of both clinical and investigative medicine. As the use of conventional antibiotics rises, antimicrobial resistance patterns develop, necessitating the continuous need for newer and more effective therapies. Nanotechnology, defined as the production and application of materials in the nanoscale range (1-100 nm), has been the focus of several investigations as a result of unique physical and chemical properties of nanomaterials. Specifically, nanomaterials provide added benefits due to their small size, allowing for an increased ability to surpass most physiologic barriers and reach their intended targets, and high surface-area-to-volume ratio, allowing for increased potential to interact with pathogen membranes and cell walls. This review focuses of the potential therapeutic and preventative applications of nanotechnology-based drug delivery systems in infectious disease.

Original languageEnglish (US)
Pages (from-to)395-401
Number of pages7
JournalVirulence
Volume2
Issue number5
DOIs
StatePublished - Sep 2011

Fingerprint

Nanotechnology
Communicable Diseases
Nanostructures
Clinical Medicine
Drug Delivery Systems
Cell Wall
Biomedical Research
Therapeutics
Anti-Bacterial Agents
Membranes

Keywords

  • Antibiotic
  • Antimicrobial
  • Nanotechnology
  • Vaccine

ASJC Scopus subject areas

  • Infectious Diseases
  • Microbiology
  • Parasitology
  • Immunology
  • Microbiology (medical)

Cite this

The growing role of nanotechnology in combating infectious disease. / Blecher Paz, Karin; Nasir, Adnan; Friedman, Adam.

In: Virulence, Vol. 2, No. 5, 09.2011, p. 395-401.

Research output: Contribution to journalReview article

Blecher Paz, Karin ; Nasir, Adnan ; Friedman, Adam. / The growing role of nanotechnology in combating infectious disease. In: Virulence. 2011 ; Vol. 2, No. 5. pp. 395-401.
@article{e14169444b0247aa8bbc1f9d4763537a,
title = "The growing role of nanotechnology in combating infectious disease",
abstract = "The treatment and prevention of infectious diseases is a major part of both clinical and investigative medicine. As the use of conventional antibiotics rises, antimicrobial resistance patterns develop, necessitating the continuous need for newer and more effective therapies. Nanotechnology, defined as the production and application of materials in the nanoscale range (1-100 nm), has been the focus of several investigations as a result of unique physical and chemical properties of nanomaterials. Specifically, nanomaterials provide added benefits due to their small size, allowing for an increased ability to surpass most physiologic barriers and reach their intended targets, and high surface-area-to-volume ratio, allowing for increased potential to interact with pathogen membranes and cell walls. This review focuses of the potential therapeutic and preventative applications of nanotechnology-based drug delivery systems in infectious disease.",
keywords = "Antibiotic, Antimicrobial, Nanotechnology, Vaccine",
author = "{Blecher Paz}, Karin and Adnan Nasir and Adam Friedman",
year = "2011",
month = "9",
doi = "10.4161/viru.2.5.17035",
language = "English (US)",
volume = "2",
pages = "395--401",
journal = "Virulence",
issn = "2150-5594",
publisher = "Landes Bioscience",
number = "5",

}

TY - JOUR

T1 - The growing role of nanotechnology in combating infectious disease

AU - Blecher Paz, Karin

AU - Nasir, Adnan

AU - Friedman, Adam

PY - 2011/9

Y1 - 2011/9

N2 - The treatment and prevention of infectious diseases is a major part of both clinical and investigative medicine. As the use of conventional antibiotics rises, antimicrobial resistance patterns develop, necessitating the continuous need for newer and more effective therapies. Nanotechnology, defined as the production and application of materials in the nanoscale range (1-100 nm), has been the focus of several investigations as a result of unique physical and chemical properties of nanomaterials. Specifically, nanomaterials provide added benefits due to their small size, allowing for an increased ability to surpass most physiologic barriers and reach their intended targets, and high surface-area-to-volume ratio, allowing for increased potential to interact with pathogen membranes and cell walls. This review focuses of the potential therapeutic and preventative applications of nanotechnology-based drug delivery systems in infectious disease.

AB - The treatment and prevention of infectious diseases is a major part of both clinical and investigative medicine. As the use of conventional antibiotics rises, antimicrobial resistance patterns develop, necessitating the continuous need for newer and more effective therapies. Nanotechnology, defined as the production and application of materials in the nanoscale range (1-100 nm), has been the focus of several investigations as a result of unique physical and chemical properties of nanomaterials. Specifically, nanomaterials provide added benefits due to their small size, allowing for an increased ability to surpass most physiologic barriers and reach their intended targets, and high surface-area-to-volume ratio, allowing for increased potential to interact with pathogen membranes and cell walls. This review focuses of the potential therapeutic and preventative applications of nanotechnology-based drug delivery systems in infectious disease.

KW - Antibiotic

KW - Antimicrobial

KW - Nanotechnology

KW - Vaccine

UR - http://www.scopus.com/inward/record.url?scp=80053930419&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053930419&partnerID=8YFLogxK

U2 - 10.4161/viru.2.5.17035

DO - 10.4161/viru.2.5.17035

M3 - Review article

VL - 2

SP - 395

EP - 401

JO - Virulence

JF - Virulence

SN - 2150-5594

IS - 5

ER -